Skip to main content
Review Article
Originally Published 24 January 2024
Free Access

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Seth S. Martin, MD, MHS, FAHA, Chair, Aaron W. Aday, MD, MSc, FAHA, Zaid I. Almarzooq, MBBCh, MPH, Cheryl A.M. Anderson, PhD, MPH, FAHA, Pankaj Arora, MD, FAHA, Christy L. Avery, PhD, MPH, FAHA, Carissa M. Baker-Smith, MD, MPH, FAHA, Show All , Bethany Barone Gibbs, PhD, MSc, FAHA, Andrea Z. Beaton, MD, MS, FAHA, Amelia K. Boehme, PhD, MSPH, Yvonne Commodore-Mensah, PhD, MHS, RN, FAHA, Maria E. Currie, MD, PhD, Mitchell S.V. Elkind, MD, MS, FAHA, Kelly R. Evenson, PhD, MS, FAHA, Giuliano Generoso, MD, PhD, Debra G. Heard, PhD, Swapnil Hiremath, MD, MPH, FAHA, Michelle C. Johansen, MD, PhD, Rizwan Kalani, MD, Dhruv S. Kazi, MD, MSc, MS, FAHA, Darae Ko, MD, MSc;, Junxiu Liu, PhD, Jared W. Magnani, MD, MS, FAHA, Erin D. Michos, MD, MHSc, FAHA, Michael E. Mussolino, PhD, FAHA, Sankar D. Navaneethan, MD, MS, MPH, Nisha I. Parikh, MD, MPH, Sarah M. Perman, MD, MSCE, MS, FAHA, Remy Poudel, MS, MPH, CPH, Mary Rezk-Hanna, PhD, FAHA, Gregory A. Roth, MD, MPH, FAHA, Nilay S. Shah, MD, MPH, FAHA, Marie-Pierre St-Onge, PhD, FAHA, Evan L. Thacker, PhD, Connie W. Tsao, MD, MPH, FAHA, Sarah M. Urbut, MD, PhD, Harriette G.C. Van Spall, MD, MPH, Jenifer H. Voeks, PhD, FAHA, Nae-Yuh Wang, PhD, MS, FAHA, Nathan D. Wong, PhD, MPH, FAHA, Sally S. Wong, PhD, RD, CDN, FAHA, Kristine Yaffe, MD, and Latha P. Palaniappan, MD, MS, FAHA, Vice Chair on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeAuthor Info & Affiliations
This article has been corrected.
VIEW CORRECTION

Abstract

BACKGROUND:

The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).

METHODS:

The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional global data, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains.

RESULTS:

Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.

CONCLUSIONS:

The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

Supplemental Material

File (europe and central asia cvd statistics supplement.pdf)
File (global cvd statistics supplement.pdf)
File (high-income countries cvd statistics supplement.pdf)
File (latin america and caribbean cvd statistics supplement.pdf)
File (north africa and middle east cvd statistics supplement.pdf)
File (south asia cvd statistics supplement.pdf)
File (southeast and east asia and oceania cvd statistics supplement.pdf)
File (sub-saharan africa cvd statistics supplement.pdf)

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation
Go to Circulation
Circulation
Pages: e347 - e913
PubMed: 38264914

Versions

You are viewing the most recent version of this article.

History

Published online: 24 January 2024
Published in print: 20 February 2024

Permissions

Request permissions for this article.

Keywords

  1. AHA Scientific Statements
  2. cardiovascular diseases
  3. epidemiology
  4. risk factors
  5. statistics
  6. stroke

Subjects

Authors

Affiliations

Seth S. Martin, MD, MHS, FAHA, Chair
Aaron W. Aday, MD, MSc, FAHA
Zaid I. Almarzooq, MBBCh, MPH
Cheryl A.M. Anderson, PhD, MPH, FAHA
Pankaj Arora, MD, FAHA
Christy L. Avery, PhD, MPH, FAHA
Carissa M. Baker-Smith, MD, MPH, FAHA
Bethany Barone Gibbs, PhD, MSc, FAHA
Andrea Z. Beaton, MD, MS, FAHA
Amelia K. Boehme, PhD, MSPH
Yvonne Commodore-Mensah, PhD, MHS, RN, FAHA
Maria E. Currie, MD, PhD
Mitchell S.V. Elkind, MD, MS, FAHA
Kelly R. Evenson, PhD, MS, FAHA
Giuliano Generoso, MD, PhD
Swapnil Hiremath, MD, MPH, FAHA
Michelle C. Johansen, MD, PhD
Dhruv S. Kazi, MD, MSc, MS, FAHA
Jared W. Magnani, MD, MS, FAHA
Erin D. Michos, MD, MHSc, FAHA
Michael E. Mussolino, PhD, FAHA
Sankar D. Navaneethan, MD, MS, MPH
Nisha I. Parikh, MD, MPH
Sarah M. Perman, MD, MSCE, MS, FAHA
Remy Poudel, MS, MPH, CPH
Mary Rezk-Hanna, PhD, FAHA
Gregory A. Roth, MD, MPH, FAHA
Nilay S. Shah, MD, MPH, FAHA
Marie-Pierre St-Onge, PhD, FAHA
Connie W. Tsao, MD, MPH, FAHA
Sarah M. Urbut, MD, PhD
Harriette G.C. Van Spall, MD, MPH
Jenifer H. Voeks, PhD, FAHA
Nae-Yuh Wang, PhD, MS, FAHA
Nathan D. Wong, PhD, MPH, FAHA
Sally S. Wong, PhD, RD, CDN, FAHA
Latha P. Palaniappan, MD, MS, FAHA, Vice Chair
on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee

Notes

The 2024 AHA Statistical Update uses language that conveys respect and specificity when referencing race and ethnicity. Instead of referring to groups very broadly with collective nouns (eg, Blacks, Whites), we use descriptions of race and ethnicity as adjectives (eg, Asian people, Black adults, Hispanic youths, Native American patients, White females).
As the AHA continues its focus on health equity to address structural racism, we are working to reconcile language used in previously published data sources and studies when this information is compiled in the annual Statistical Update. We strive to use terms from the original data sources or published studies (mostly from the past 5 years) that may not be as inclusive as the terms used in 2024. As style guidelines for scientific writing evolve, they will serve as guidance for data sources and publications and how they are cited in future Statistical Updates.
Supplemental Material is available at Supplemental Material
The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; the US Department of Health and Human Services; or the US Department of Veterans Affairs.
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
A copy of the document is available at https://professional.heart.org/statements by using either “Search for Guidelines & Statements” or the “Browse by Topic” area. To purchase additional reprints, call 215-356-2721 or email [email protected]
The American Heart Association requests that this document be cited as follows: Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, Commodore-Mensah Y, Currie ME, Elkind MSV, Evenson KR, Generoso G, Heard DG, Hiremath S, Johansen MC, Kalani R, Kazi DS, Ko D, Liu J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Perman SM, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge M-P, Thacker EL, Tsao CW, Urbut SM, Van Spall HGC, Voeks JH, Wang N-Y, Wong ND, Wong SS, Yaffe K, Palaniappan LP; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149:e347–e913. doi: 10.1161/CIR.0000000000001209
The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit https://professional.heart.org/statements. Select the “Guidelines & Statements” drop-down menu, then click “Publication Development.”
Permissions: Multiple copies, modification, alteration, enhancement, and distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at https://www.heart.org/permissions. A link to the “Copyright Permissions Request Form” appears in the second paragraph (https://www.heart.org/en/about-us/statements-and-policies/copyright-request-form).
Circulation is available at www.ahajournals.org/journal/circ

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Advance in the application of 4-dimensional flow MRI in atrial fibrillation, Magnetic Resonance Imaging, 115, (110254), (2025).https://doi.org/10.1016/j.mri.2024.110254
    Crossref
  2. Targeting cancer with novel tetra-1,2,3-triazole hybrids: Synthesis, biological evaluation, and molecular dynamics, Journal of Molecular Structure, 1321, (140245), (2025).https://doi.org/10.1016/j.molstruc.2024.140245
    Crossref
  3. Prediabetes and the Risk of Peripheral Artery Disease: A Meta-Analysis, Annals of Vascular Surgery, 110, (274-285), (2025).https://doi.org/10.1016/j.avsg.2024.06.045
    Crossref
  4. Comparative Efficacy and Safety of Novel Antiplatelets and Standard Therapy in Patients With Coronary Artery Disease, Cureus, (2024).https://doi.org/10.7759/cureus.71333
    Crossref
  5. Cardiovascular Disease in Women and the Role of Hormone Replacement Therapy, Cureus, (2024).https://doi.org/10.7759/cureus.69752
    Crossref
  6. Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence, Journal of Comparative Effectiveness Research, 13, 6, (2024).https://doi.org/10.57264/cer-2024-0008
    Crossref
  7. “East Asian Paradox” Revisited: Precision Medicine for Antithrombotic Strategies Tailored to Atherothrombotic Cardiovascular Risks, Journal of Cardiovascular Intervention, 3, 3, (119), (2024).https://doi.org/10.54912/jci.2024.0006
    Crossref
  8. Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis, World Journal of Diabetes, 15, 8, (1659-1662), (2024).https://doi.org/10.4239/wjd.v15.i8.1659
    Crossref
  9. Cardiovascular Risk Awareness, Exercise Practices and Metabolic Outcomes among Patients with Diabetes Mellitus in Northern Nigeria: A Cross-sectional, Multicentre Study, Nigerian Postgraduate Medical Journal, 31, 2, (139-146), (2024).https://doi.org/10.4103/npmj.npmj_54_24
    Crossref
  10. Cardiorenal Benefit of Tirzepatide in Type 1 Diabetes: A Case Report, Journal of Diabetology, 15, 4, (447-451), (2024).https://doi.org/10.4103/jod.jod_97_24
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this journal for 24 hours

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response